Alfred D. Kingsley
Director, Lineage Cell Therapeutics.
Companies
- Lineage Cell TherapeuticsChair Jul 3, 2023 to Jul 3, 20231
- Insight Molecular Diagnostics Inc.Board member Dec 31, 2015 to Jun 27, 20232
- Lineage Cell TherapeuticsBoard member Jul 6, 2009 to Feb 14, 20233
- Lineage Cell TherapeuticsOfficer Jul 6, 2011 to Jul 3, 20184
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Lineage Cell Therapeutics LCTX5,805,896 shares5$5.5M at $0.95Feb 14, 2023- Insight Molecular Diagnostics Inc. IMDX507,878 shares6$1.5M at $2.95Jun 27, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 23, 2023Granted 20,000 shares of Insight Molecular Diagnostics Inc.6
- Jun 14, 2023Bought 30,000 shares at $0.21 of Insight Molecular Diagnostics Inc.7
- Dec 22, 2022Bought 25,000 shares at $0.29 of Insight Molecular Diagnostics Inc.8
- Dec 1, 2022Gift 25,000 shares of Lineage Cell Therapeutics5
- Aug 15, 2022Bought 5,000 shares at $0.97 of Insight Molecular Diagnostics Inc.9
- Aug 15, 2022Bought 5,000 shares at $0.97 of Insight Molecular Diagnostics Inc.9
- Aug 15, 2022Granted 10,000 shares of Insight Molecular Diagnostics Inc.9
- Jun 24, 2022Exercised options 10,000 shares of Insight Molecular Diagnostics Inc.10
- Dec 1, 2021Gift 14,700 shares of Lineage Cell Therapeutics11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARLineage Cell Therapeutics, Chair
- 2
- 3
- 4SEC EDGARLineage Cell Therapeutics, Officer
- 5
- 6
- 7SEC EDGARForm 4 filed Jun 15, 2023
- 8SEC EDGARForm 4 filed Dec 27, 2022
- 9SEC EDGARForm 4 filed Aug 17, 2022
- 10SEC EDGARForm 4 filed Jul 19, 2022
- 11SEC EDGARForm 5 filed Feb 11, 2022